These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

215 related articles for article (PubMed ID: 24130757)

  • 1. Molecular dynamics simulations of DNA-free and DNA-bound TAL effectors.
    Wan H; Hu JP; Li KS; Tian XH; Chang S
    PLoS One; 2013; 8(10):e76045. PubMed ID: 24130757
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Potential Role of the Last Half Repeat in TAL Effectors Revealed by a Molecular Simulation Study.
    Wan H; Chang S; Hu JP; Tian XH; Wang MH
    Biomed Res Int; 2016; 2016():8036450. PubMed ID: 27803930
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Revisiting the TALE repeat.
    Deng D; Yan C; Wu J; Pan X; Yan N
    Protein Cell; 2014 Apr; 5(4):297-306. PubMed ID: 24622844
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Non-RVD mutations that enhance the dynamics of the TAL repeat array along the superhelical axis improve TALEN genome editing efficacy.
    Tochio N; Umehara K; Uewaki JI; Flechsig H; Kondo M; Dewa T; Sakuma T; Yamamoto T; Saitoh T; Togashi Y; Tate SI
    Sci Rep; 2016 Nov; 6():37887. PubMed ID: 27883072
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Structural basis for sequence-specific recognition of DNA by TAL effectors.
    Deng D; Yan C; Pan X; Mahfouz M; Wang J; Zhu JK; Shi Y; Yan N
    Science; 2012 Feb; 335(6069):720-3. PubMed ID: 22223738
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Conformational elasticity can facilitate TALE-DNA recognition.
    Lei H; Sun J; Baldwin EP; Segal DJ; Duan Y
    Adv Protein Chem Struct Biol; 2014; 94():347-64. PubMed ID: 24629191
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Structural Insights into the Specific Recognition of 5-methylcytosine and 5-hydroxymethylcytosine by TAL Effectors.
    Liu L; Zhang Y; Liu M; Wei W; Yi C; Peng J
    J Mol Biol; 2020 Feb; 432(4):1035-1047. PubMed ID: 31863750
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Specific DNA-RNA hybrid recognition by TAL effectors.
    Yin P; Deng D; Yan C; Pan X; Xi JJ; Yan N; Shi Y
    Cell Rep; 2012 Oct; 2(4):707-13. PubMed ID: 23022487
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Deciphering TAL effectors for 5-methylcytosine and 5-hydroxymethylcytosine recognition.
    Zhang Y; Liu L; Guo S; Song J; Zhu C; Yue Z; Wei W; Yi C
    Nat Commun; 2017 Oct; 8(1):901. PubMed ID: 29026078
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Evolution of Transcription Activator-Like Effectors in Xanthomonas oryzae.
    Erkes A; Reschke M; Boch J; Grau J
    Genome Biol Evol; 2017 Jun; 9(6):1599-1615. PubMed ID: 28637323
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Quantitative analysis of TALE-DNA interactions suggests polarity effects.
    Meckler JF; Bhakta MS; Kim MS; Ovadia R; Habrian CH; Zykovich A; Yu A; Lockwood SH; Morbitzer R; Elsäesser J; Lahaye T; Segal DJ; Baldwin EP
    Nucleic Acids Res; 2013 Apr; 41(7):4118-28. PubMed ID: 23408851
    [TBL] [Abstract][Full Text] [Related]  

  • 12. A TALE-inspired computational screen for proteins that contain approximate tandem repeats.
    Perycz M; Krwawicz J; Bochtler M
    PLoS One; 2017; 12(6):e0179173. PubMed ID: 28617832
    [TBL] [Abstract][Full Text] [Related]  

  • 13. TAL effectors: function, structure, engineering and applications.
    Mak AN; Bradley P; Bogdanove AJ; Stoddard BL
    Curr Opin Struct Biol; 2013 Feb; 23(1):93-9. PubMed ID: 23265998
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Structural basis of the TAL effector-DNA interaction.
    Bochtler M
    Biol Chem; 2012 Oct; 393(10):1055-66. PubMed ID: 23089535
    [TBL] [Abstract][Full Text] [Related]  

  • 15. TAL effectors specificity stems from negative discrimination.
    Wicky BI; Stenta M; Dal Peraro M
    PLoS One; 2013; 8(11):e80261. PubMed ID: 24282528
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Regulation of selected genome loci using de novo-engineered transcription activator-like effector (TALE)-type transcription factors.
    Morbitzer R; Römer P; Boch J; Lahaye T
    Proc Natl Acad Sci U S A; 2010 Dec; 107(50):21617-22. PubMed ID: 21106758
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Exploiting the sequence diversity of TALE-like repeats to vary the strength of dTALE-promoter interactions.
    de Lange O; Schandry N; Wunderlich M; Berendzen KW; Lahaye T
    Synth Biol (Oxf); 2017 Jan; 2(1):ysx004. PubMed ID: 32995505
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Computational predictions provide insights into the biology of TAL effector target sites.
    Grau J; Wolf A; Reschke M; Bonas U; Posch S; Boch J
    PLoS Comput Biol; 2013; 9(3):e1002962. PubMed ID: 23526890
    [TBL] [Abstract][Full Text] [Related]  

  • 19. The crystal structure of TAL effector PthXo1 bound to its DNA target.
    Mak AN; Bradley P; Cernadas RA; Bogdanove AJ; Stoddard BL
    Science; 2012 Feb; 335(6069):716-9. PubMed ID: 22223736
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Context and number of noncanonical repeat variable diresidues impede the design of TALE proteins with improved DNA targeting.
    Anderson JT; Rogers JM; Barrera LA; Bulyk ML
    Protein Sci; 2020 Feb; 29(2):606-616. PubMed ID: 31833142
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 11.